Business Insider17d
Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid
RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Merakris Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted clearance to commence Part 2 of ...
STAT23d
FDA clears updated Covid shots from Novavax, adding a 3rd fall vaccine option
Those doses can be used in adults and children as young as 6 months. On Friday, the Food and Drug Administration gave the OK to the updated Novavax formula, too — and those shots are open to ...
FierceBiotech24d
FDA's drug center to consolidate AI efforts under single council
The FDA’s Center for Drug Evaluation and Research (CDER) is consolidating its artificial-intelligence-related activities under a single AI Council, in part in response to efforts from the Biden ...
Federal Register24d
Schedules of Controlled Substances: Rescheduling of Marijuana
Design Updates: As part of our ongoing effort to make FederalRegister.gov more accessible and easier to use we've enlarged the space available to the document content and moved all document related ...